Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 4
2019 3
2020 1
2021 4
2022 10
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Secondary Sclerosing Cholangitis After Emphysematous Cholecystitis.
Takahashi K, Ohyama H, Takiguchi Y, Sekine Y, Toyama S, Yamada N, Sugihara C, Kan M, Ouchi M, Nagashima H, Iino Y, Kusakabe Y, Okitsu K, Ohno I, Kato N. Takahashi K, et al. Among authors: kan m. ACG Case Rep J. 2023 Mar 23;10(3):e01016. doi: 10.14309/crj.0000000000001016. eCollection 2023 Mar. ACG Case Rep J. 2023. PMID: 36968126 Free PMC article.
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma.
Qiang N, Ao J, Nakamura M, Chiba T, Kusakabe Y, Kaneko T, Kurosugi A, Kogure T, Ma Y, Zhang J, Ogawa K, Kan M, Iwanaga T, Sakuma T, Kanayama K, Kanzaki H, Kojima R, Nakagawa R, Kondo T, Nakamoto S, Muroyama R, Kato J, Mimura N, Ma A, Jin J, Kato N. Qiang N, et al. Among authors: kan m. Int Immunopharmacol. 2023 May;118:110068. doi: 10.1016/j.intimp.2023.110068. Epub 2023 Mar 29. Int Immunopharmacol. 2023. PMID: 37001386
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Ogawa K, Chiba T, Nakamura M, Arai J, Zhang J, Ma Y, Qiang NA, Ao J, Yumita S, Ishino T, Kan M, Iwanaga T, Nakagawa M, Fujiwara K, Sakuma T, Kanzaki H, Koroki K, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Kondo T, Nakagawa R, Ogasawara S, Muroyama R, Nakamoto S, Kanda T, Maruyama H, Kato J, Matsumoto S, Arai T, Motohashi S, Kato N. Ogawa K, et al. Among authors: kan m. Anticancer Res. 2023 Mar;43(3):1043-1052. doi: 10.21873/anticanres.16249. Anticancer Res. 2023. PMID: 36854524
"Salvage techniques" are the key to overcome difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.
Maruta S, Sugiyama H, Ogasawara S, Sugihara C, Ouchi M, Kan M, Yamada T, Miura Y, Nagashima H, Takahashi K, Kusakabe Y, Ohyama H, Okitsu K, Ohno I, Mikata R, Sakai Y, Tsuyuguchi T, Kato J, Kato N. Maruta S, et al. Among authors: kan m. Sci Rep. 2022 Aug 10;12(1):13627. doi: 10.1038/s41598-022-17809-5. Sci Rep. 2022. PMID: 35948566 Free PMC article.
Diagnostic value of peroral cholangioscopy in addition to computed tomography for indeterminate biliary strictures.
Shima Y, Sugiyama H, Ogasawara S, Kan M, Maruta S, Yamada T, Miura Y, Asano K, Sensui M, Nagashima H, Yokoyama M, Kusakabe Y, Yasui S, Ohno I, Mikata R, Tsuyuguchi T, Horikoshi T, Mishima T, Kuboki S, Takayashiki T, Ohtsuka M, Kato J, Kato N. Shima Y, et al. Among authors: kan m. Surg Endosc. 2022 May;36(5):3408-3417. doi: 10.1007/s00464-021-08661-1. Epub 2021 Aug 9. Surg Endosc. 2022. PMID: 34370123
Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis.
Sensui M, Yasui S, Ogasawara S, Kamezaki H, Kan M, Maruta S, Yamada T, Miura Y, Asano K, Shima Y, Nagashima H, Yokoyama M, Kusakabe Y, Sugiyama H, Ohno I, Mikata R, Kato J, Tsuyuguchi T, Kato N. Sensui M, et al. Among authors: kan m. Ann Hepatol. 2022 May-Jun;27(3):100696. doi: 10.1016/j.aohep.2022.100696. Epub 2022 Mar 5. Ann Hepatol. 2022. PMID: 35257932 Free article.
Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells.
Ao J, Chiba T, Shibata S, Kurosugi A, Qiang N, Ma Y, Kan M, Iwanaga T, Sakuma T, Kanzaki H, Kanayama K, Kojima R, Kusakabe Y, Nakamura M, Saito T, Nakagawa R, Kondo T, Ogasawara S, Suzuki E, Muroyama R, Kato J, Mimura N, Kanda T, Maruyama H, Kato N. Ao J, et al. Among authors: kan m. Biochem Biophys Res Commun. 2021 Apr 16;549:171-178. doi: 10.1016/j.bbrc.2021.02.097. Epub 2021 Mar 3. Biochem Biophys Res Commun. 2021. PMID: 33676186
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.
Sakuma T, Nakamura M, Chiba T, Iwanaga T, Kan M, Kojima R, Ao J, Ma Y, Unozawa H, Fujita N, Kanayama K, Kanzaki H, Koroki K, Kobayashi K, Nakagawa R, Kanogawa N, Kiyono S, Kondo T, Saito T, Ogasawara S, Nakamoto S, Muroyama R, Kato J, Kishimoto T, Kato N. Sakuma T, et al. Among authors: kan m. Lab Invest. 2022 Oct;102(10):1150-1157. doi: 10.1038/s41374-022-00807-6. Epub 2022 May 28. Lab Invest. 2022. PMID: 35643859 Free article.
30 results